Chromadex Corp Stock OTC Bulletin Board
Equities
CDXC
US1710771007
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
07-01 | ChromaDex Joins Russell 2000 Index | MT |
07-01 | ChromaDex Corporation(NasdaqCM:CDXC) added to Russell Small Cap Completeness Index | CI |
Sales 2024 * | 96.57M 132M | Sales 2025 * | 114M 156M | Capitalization | 210M 287M |
---|---|---|---|---|---|
Net income 2024 * | -1M -1.37M | Net income 2025 * | 4M 5.48M | EV / Sales 2024 * | 2.17 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.84 x |
P/E ratio 2024 * |
-346
x | P/E ratio 2025 * |
44.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 64.21% |
Latest transcript on Chromadex Corp
Managers | Title | Age | Since |
---|---|---|---|
Robert Fried
CEO | Chief Executive Officer | 64 | 15-07-08 |
Frank Jaksch
FOU | Founder | 55 | 98-12-31 |
Brianna Gerber
DFI | Director of Finance/CFO | 44 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Rubin
BRD | Director/Board Member | 63 | 17-03-26 |
Hamed Shahbazi
BRD | Director/Board Member | 49 | 22-08-08 |
Frank Jaksch
FOU | Founder | 55 | 98-12-31 |
1st Jan change | Capi. | |
---|---|---|
+22.15% | 46.56B | |
+45.94% | 41.67B | |
-2.37% | 41.16B | |
+33.84% | 32.4B | |
-6.35% | 28.1B | |
+20.42% | 28.18B | |
+48.83% | 14.52B | |
+45.00% | 13.74B | |
+0.06% | 12.17B |
- Stock Market
- Equities
- CDXC Stock
- CDXC Stock